http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8843320-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac5284a11dfaf0dbe7fbf67cbfd423e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07e3ed1be7da71aa4a7c41c71f2fc4e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bf7439808d578ab8c3698f7560fe4ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90e1c52b7b2205b295f8a8d889e0f951
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
filingDate 2005-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_709cbaaa1e64bea13269f27f4d3e148e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a9fb1ec5f22ae3e24921f449ce0d649
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9d35e31e382e75b01f96ec7bd34b988
publicationDate 2014-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8843320-B2
titleOfInvention Use of gene expression profiling to predict survival in cancer patient
abstract Gene expression profiling in multiple myeloma patients identifies genes that distinguish between patients with subsequent early death or long survival after treatment. Poor survival is linked to over-expression of genes such as ASPM, OPN3 and CKS1B which are located in chromosome 1q. Given the frequent amplification of 1q in many cancers, it is possible that these genes can be used as powerful prognostic markers and therapeutic targets for multiple myeloma and other cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10597729-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9650677-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018089807-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019018540-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9822419-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10752956-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484604-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434301-B2
priorityDate 2004-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005116259-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006133361-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005164231-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010316629-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7308364-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004053066-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004009541-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013338025-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7741035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2390662-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7863424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7935679-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243697934

Total number of triples: 48.